Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway.

Sui J, Aird DR, Tamin A, Murakami A, Yan M, Yammanuru A, Jing H, Kan B, Liu X, Zhu Q, Yuan QA, Adams GP, Bellini WJ, Xu J, Anderson LJ, Marasco WA.

PLoS Pathog. 2008 Nov;4(11):e1000197. doi: 10.1371/journal.ppat.1000197. Epub 2008 Nov 7.

2.

Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.

Lim AP, Chan CE, Wong SK, Chan AH, Ooi EE, Hanson BJ.

Virol J. 2008 Oct 28;5:130. doi: 10.1186/1743-422X-5-130.

3.

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor.

Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO.

Nature. 2008 Jul 10;454(7201):177-82. doi: 10.1038/nature07082.

4.

Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies.

Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, Wall KM, Perry KJ, Faynboym A, Ilhan M, Horowitz M, Horowitz L, Palese P, Bhatt RR, Lerner RA.

Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):5986-91. doi: 10.1073/pnas.0801367105. Epub 2008 Apr 14.

5.

Emerging influenza.

de Wit E, Fouchier RA.

J Clin Virol. 2008 Jan;41(1):1-6. Review.

6.

Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine.

Leroux-Roels I, Bernhard R, Gérard P, Dramé M, Hanon E, Leroux-Roels G.

PLoS One. 2008 Feb 27;3(2):e1665. doi: 10.1371/journal.pone.0001665.

7.

Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140.

Selvarajah S, Puffer BA, Lee FH, Zhu P, Li Y, Wyatt R, Roux KH, Doms RW, Burton DR.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):301-14. doi: 10.1089/aid.2007.0158.

PMID:
18284327
8.

Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine.

Baras B, Stittelaar KJ, Simon JH, Thoolen RJ, Mossman SP, Pistoor FH, van Amerongen G, Wettendorff MA, Hanon E, Osterhaus AD.

PLoS One. 2008 Jan 2;3(1):e1401. doi: 10.1371/journal.pone.0001401.

9.

Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity.

Scherer EM, Zwick MB, Teyton L, Burton DR.

AIDS. 2007 Oct 18;21(16):2131-9.

PMID:
18090039
10.

The growth and potential of human antiviral monoclonal antibody therapeutics.

Marasco WA, Sui J.

Nat Biotechnol. 2007 Dec;25(12):1421-34. Review.

PMID:
18066039
11.

Analysis of residues near the fusion peptide in the influenza hemagglutinin structure for roles in triggering membrane fusion.

Thoennes S, Li ZN, Lee BJ, Langley WA, Skehel JJ, Russell RJ, Steinhauer DA.

Virology. 2008 Jan 20;370(2):403-14. Epub 2007 Oct 23.

12.

Influenza vaccine: the challenge of antigenic drift.

Carrat F, Flahault A.

Vaccine. 2007 Sep 28;25(39-40):6852-62. Epub 2007 Aug 3. Review.

PMID:
17719149
13.

The threat of avian influenza A (H5N1). Part IV: Development of vaccines.

Cinatl J Jr, Michaelis M, Doerr HW.

Med Microbiol Immunol. 2007 Dec;196(4):213-25. Epub 2007 Jun 1. Review.

PMID:
17541633
14.

FastContact: a free energy scoring tool for protein-protein complex structures.

Champ PC, Camacho CJ.

Nucleic Acids Res. 2007 Jul;35(Web Server issue):W556-60. Epub 2007 May 30.

15.

H5N1 viruses and vaccines.

Subbarao K, Luke C.

PLoS Pathog. 2007 Mar;3(3):e40. Review. No abstract available.

16.

Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.

Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y.

Nature. 2006 Nov 16;444(7117):378-82.

PMID:
17108965
17.

Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R.

Hwang WC, Lin Y, Santelli E, Sui J, Jaroszewski L, Stec B, Farzan M, Marasco WA, Liddington RC.

J Biol Chem. 2006 Nov 10;281(45):34610-6. Epub 2006 Sep 5.

18.

Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody.

Luftig MA, Mattu M, Di Giovine P, Geleziunas R, Hrin R, Barbato G, Bianchi E, Miller MD, Pessi A, Carfí A.

Nat Struct Mol Biol. 2006 Aug;13(8):740-7. Epub 2006 Jul 23.

PMID:
16862157
19.

Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus.

Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA.

Science. 2006 Apr 21;312(5772):404-10. Epub 2006 Mar 16.

20.

Pandemic influenza threat and preparedness.

Fauci AS.

Emerg Infect Dis. 2006 Jan;12(1):73-7. Review.

Supplemental Content

Support Center